位置:首页 > 蛋白库 > TAF3_MOUSE
TAF3_MOUSE
ID   TAF3_MOUSE              Reviewed;         932 AA.
AC   Q5HZG4; Q3U490; Q3UWX2; Q8BIU8; Q99JH4;
DT   11-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   11-JUL-2006, sequence version 2.
DT   03-AUG-2022, entry version 141.
DE   RecName: Full=Transcription initiation factor TFIID subunit 3;
DE   AltName: Full=140 kDa TATA box-binding protein-associated factor;
DE   AltName: Full=TBP-associated factor 3;
DE   AltName: Full=Transcription initiation factor TFIID 140 kDa subunit;
DE            Short=TAF(II)140;
DE            Short=TAF140;
DE            Short=TAFII-140;
DE            Short=TAFII140;
GN   Name=Taf3;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND INTERACTION WITH TAF10.
RC   TISSUE=Embryonic carcinoma;
RX   PubMed=11438666; DOI=10.1128/mcb.21.15.5109-5121.2001;
RA   Gangloff Y.G., Pointud J.-C., Thuault S., Carre L., Romier C.,
RA   Muratoglu S., Brand M., Tora L., Couderc J.-L., Davidson I.;
RT   "The TFIID components human TAFII140 and Drosophila BIP2 (TAFII155) are
RT   novel metazoan homologues of yeast TAFII47 containing a histone fold and a
RT   PHD finger.";
RL   Mol. Cell. Biol. 21:5109-5121(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   STRAIN=C57BL/6J, and NOD; TISSUE=Dendritic cell, Egg, and Heart;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=C57BL/6J; TISSUE=Head;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH TBPL2.
RX   PubMed=17704303; DOI=10.1101/gad.1583407;
RA   Deato M.D.E., Tjian R.;
RT   "Switching of the core transcription machinery during myogenesis.";
RL   Genes Dev. 21:2137-2149(2007).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-183, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brown adipose tissue, Kidney, Lung, Pancreas, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-266, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic fibroblast;
RX   PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;
RA   Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y.,
RA   Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;
RT   "SIRT5-mediated lysine desuccinylation impacts diverse metabolic
RT   pathways.";
RL   Mol. Cell 50:919-930(2013).
RN   [7]
RP   STRUCTURE BY NMR OF 857-924 IN COMPLEX WITH H3K4ME3 PEPTIDE.
RX   PubMed=18682226; DOI=10.1016/j.str.2008.04.015;
RA   van Ingen H., van Schaik F.M., Wienk H., Ballering J., Rehmann H.,
RA   Dechesne A.C., Kruijzer J.A., Liskamp R.M., Timmers H.T., Boelens R.;
RT   "Structural insight into the recognition of the H3K4me3 mark by the TFIID
RT   subunit TAF3.";
RL   Structure 16:1245-1256(2008).
CC   -!- FUNCTION: The TFIID basal transcription factor complex plays a major
CC       role in the initiation of RNA polymerase II (Pol II)-dependent
CC       transcription (By similarity). TFIID recognizes and binds promoters
CC       with or without a TATA box via its subunit TBP, a TATA-box-binding
CC       protein, and promotes assembly of the pre-initiation complex (PIC) (By
CC       similarity). The TFIID complex consists of TBP and TBP-associated
CC       factors (TAFs), including TAF1, TAF2, TAF3, TAF4, TAF5, TAF6, TAF7,
CC       TAF8, TAF9, TAF10, TAF11, TAF12 and TAF13 (By similarity). The TFIID
CC       complex structure can be divided into 3 modules TFIID-A, TFIID-B, and
CC       TFIID-C (By similarity). TAF3 forms the TFIID-A module together with
CC       TAF5 and TBP (By similarity). Required in complex with TBPL2 for the
CC       differentiation of myoblasts into myocytes (PubMed:17704303). The TAF3-
CC       TBPL2 complex replaces TFIID at specific promoters at an early stage in
CC       the differentiation process (PubMed:17704303).
CC       {ECO:0000250|UniProtKB:Q5VWG9, ECO:0000269|PubMed:17704303}.
CC   -!- SUBUNIT: Component of the TFIID basal transcription factor complex,
CC       composed of TATA-box-binding protein TBP, and a number of TBP-
CC       associated factors (TAFs), including TAF1, TAF2, TAF3, TAF4, TAF5,
CC       TAF6, TAF7, TAF8, TAF9, TAF10, TAF11, TAF12 and TAF13 (By similarity).
CC       Interacts with TAF10 via histone fold (PubMed:11438666). Interacts with
CC       TAF13, TBP, SAP130 and GCN5L2 (By similarity). Interacts with TBPL2
CC       (PubMed:17704303). {ECO:0000250|UniProtKB:Q5VWG9,
CC       ECO:0000269|PubMed:11438666, ECO:0000269|PubMed:17704303}.
CC   -!- INTERACTION:
CC       Q5HZG4; Q6SJ95: Tbpl2; NbExp=3; IntAct=EBI-1561080, EBI-1571412;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17704303}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q5HZG4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q5HZG4-2; Sequence=VSP_019736, VSP_019737;
CC   -!- DOMAIN: The PHD-type zinc finger mediates binding to histone H3
CC       methyllysine at position 4 (H3K4me3). {ECO:0000269|PubMed:18682226}.
CC   -!- SIMILARITY: Belongs to the TAF3 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH89030.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ292189; CAC34476.1; -; mRNA.
DR   EMBL; AK084574; BAC39218.1; -; mRNA.
DR   EMBL; AK136045; BAE22792.1; -; mRNA.
DR   EMBL; AK154372; BAE32543.1; -; mRNA.
DR   EMBL; BC089030; AAH89030.1; ALT_INIT; mRNA.
DR   CCDS; CCDS15675.1; -. [Q5HZG4-1]
DR   RefSeq; NP_082024.2; NM_027748.3. [Q5HZG4-1]
DR   PDB; 2K16; NMR; -; A=857-924.
DR   PDB; 2K17; NMR; -; A=857-924.
DR   PDBsum; 2K16; -.
DR   PDBsum; 2K17; -.
DR   AlphaFoldDB; Q5HZG4; -.
DR   BMRB; Q5HZG4; -.
DR   SMR; Q5HZG4; -.
DR   BioGRID; 229072; 3.
DR   ComplexPortal; CPX-932; General transcription factor complex TFIID.
DR   ComplexPortal; CPX-959; General transcription factor complex TFIID, Taf4b variant.
DR   IntAct; Q5HZG4; 9.
DR   STRING; 10090.ENSMUSP00000026888; -.
DR   iPTMnet; Q5HZG4; -.
DR   PhosphoSitePlus; Q5HZG4; -.
DR   EPD; Q5HZG4; -.
DR   jPOST; Q5HZG4; -.
DR   MaxQB; Q5HZG4; -.
DR   PaxDb; Q5HZG4; -.
DR   PeptideAtlas; Q5HZG4; -.
DR   PRIDE; Q5HZG4; -.
DR   ProteomicsDB; 259350; -. [Q5HZG4-1]
DR   ProteomicsDB; 259351; -. [Q5HZG4-2]
DR   Antibodypedia; 24519; 138 antibodies from 26 providers.
DR   Ensembl; ENSMUST00000026888; ENSMUSP00000026888; ENSMUSG00000025782. [Q5HZG4-1]
DR   GeneID; 209361; -.
DR   KEGG; mmu:209361; -.
DR   UCSC; uc008ihk.2; mouse. [Q5HZG4-2]
DR   UCSC; uc008ihl.2; mouse. [Q5HZG4-1]
DR   CTD; 83860; -.
DR   MGI; MGI:2388097; Taf3.
DR   VEuPathDB; HostDB:ENSMUSG00000025782; -.
DR   eggNOG; KOG1973; Eukaryota.
DR   eggNOG; KOG2389; Eukaryota.
DR   GeneTree; ENSGT00710000106806; -.
DR   HOGENOM; CLU_014486_0_0_1; -.
DR   InParanoid; Q5HZG4; -.
DR   OMA; FPQPGAR; -.
DR   PhylomeDB; Q5HZG4; -.
DR   TreeFam; TF316513; -.
DR   Reactome; R-MMU-674695; RNA Polymerase II Pre-transcription Events.
DR   Reactome; R-MMU-6804756; Regulation of TP53 Activity through Phosphorylation.
DR   Reactome; R-MMU-73776; RNA Polymerase II Promoter Escape.
DR   Reactome; R-MMU-73779; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening.
DR   Reactome; R-MMU-75953; RNA Polymerase II Transcription Initiation.
DR   Reactome; R-MMU-76042; RNA Polymerase II Transcription Initiation And Promoter Clearance.
DR   BioGRID-ORCS; 209361; 22 hits in 79 CRISPR screens.
DR   ChiTaRS; Taf3; mouse.
DR   EvolutionaryTrace; Q5HZG4; -.
DR   PRO; PR:Q5HZG4; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   RNAct; Q5HZG4; protein.
DR   Bgee; ENSMUSG00000025782; Expressed in animal zygote and 233 other tissues.
DR   ExpressionAtlas; Q5HZG4; baseline and differential.
DR   Genevisible; Q5HZG4; MM.
DR   GO; GO:0001673; C:male germ cell nucleus; IDA:MGI.
DR   GO; GO:0031965; C:nuclear membrane; ISO:MGI.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; ISO:MGI.
DR   GO; GO:0005669; C:transcription factor TFIID complex; ISO:MGI.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0002039; F:p53 binding; IPI:BHF-UCL.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0140416; F:transcription regulator inhibitor activity; IDA:BHF-UCL.
DR   GO; GO:0051457; P:maintenance of protein location in nucleus; ISO:MGI.
DR   GO; GO:0042789; P:mRNA transcription by RNA polymerase II; ISO:MGI.
DR   GO; GO:0043433; P:negative regulation of DNA-binding transcription factor activity; IDA:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:BHF-UCL.
DR   GO; GO:0060261; P:positive regulation of transcription initiation from RNA polymerase II promoter; ISO:MGI.
DR   GO; GO:0006468; P:protein phosphorylation; ISO:MGI.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; TAS:MGI.
DR   GO; GO:0051123; P:RNA polymerase II preinitiation complex assembly; ISO:MGI.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; TAS:MGI.
DR   Gene3D; 1.10.20.10; -; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR006565; BTP.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR019786; Zinc_finger_PHD-type_CS.
DR   InterPro; IPR011011; Znf_FYVE_PHD.
DR   InterPro; IPR001965; Znf_PHD.
DR   InterPro; IPR019787; Znf_PHD-finger.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF07524; Bromo_TP; 1.
DR   Pfam; PF00628; PHD; 1.
DR   SMART; SM00576; BTP; 1.
DR   SMART; SM00249; PHD; 1.
DR   SUPFAM; SSF57903; SSF57903; 1.
DR   PROSITE; PS01359; ZF_PHD_1; 1.
DR   PROSITE; PS50016; ZF_PHD_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Isopeptide bond;
KW   Metal-binding; Nucleus; Phosphoprotein; Reference proteome; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..932
FT                   /note="Transcription initiation factor TFIID subunit 3"
FT                   /id="PRO_0000245529"
FT   ZN_FING         867..917
FT                   /note="PHD-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00146"
FT   REGION          130..201
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          213..347
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          403..465
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          480..579
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          607..657
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          681..746
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        156..170
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        171..194
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        267..285
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        413..465
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        489..503
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        506..527
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        535..579
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        607..650
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        688..702
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        711..746
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         183
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         199
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5VWG9"
FT   MOD_RES         229
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5VWG9"
FT   MOD_RES         243
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5VWG9"
FT   MOD_RES         266
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         291
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5VWG9"
FT   MOD_RES         297
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5VWG9"
FT   MOD_RES         301
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5VWG9"
FT   MOD_RES         502
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5VWG9"
FT   MOD_RES         669
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5VWG9"
FT   MOD_RES         758
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5VWG9"
FT   MOD_RES         779
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5VWG9"
FT   CROSSLNK        582
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q5VWG9"
FT   CROSSLNK        749
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q5VWG9"
FT   VAR_SEQ         1..741
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_019736"
FT   VAR_SEQ         742..747
FT                   /note="KHKHEK -> MYKFPQ (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_019737"
FT   CONFLICT        545
FT                   /note="R -> G (in Ref. 2; BAE32543)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        721
FT                   /note="K -> E (in Ref. 2; BAE22792)"
FT                   /evidence="ECO:0000305"
FT   STRAND          857..860
FT                   /evidence="ECO:0007829|PDB:2K16"
FT   STRAND          862..864
FT                   /evidence="ECO:0007829|PDB:2K16"
FT   STRAND          866..868
FT                   /evidence="ECO:0007829|PDB:2K16"
FT   TURN            871..873
FT                   /evidence="ECO:0007829|PDB:2K16"
FT   STRAND          882..884
FT                   /evidence="ECO:0007829|PDB:2K16"
FT   STRAND          886..893
FT                   /evidence="ECO:0007829|PDB:2K16"
FT   HELIX           894..897
FT                   /evidence="ECO:0007829|PDB:2K16"
FT   STRAND          905..907
FT                   /evidence="ECO:0007829|PDB:2K16"
FT   TURN            912..914
FT                   /evidence="ECO:0007829|PDB:2K16"
FT   HELIX           915..918
FT                   /evidence="ECO:0007829|PDB:2K16"
SQ   SEQUENCE   932 AA;  105115 MW;  8061D8E599A650EE CRC64;
     MCESYSRSLL RVSVAQICQA LGWDSVQLSA CHLLTDVLQR YLQQLGRGCH RYSELYGRTD
     PILDDVGEAF QLMGVNLHEL EDYIHNIEPV TFPHQIPSFP VSKNNVLQFP QPGSKDAEER
     KDYIPDYLPP IVSSQEEEEE EQVPTDGGTS AEAMQVPLEE DDEMEEEEVI NDENFLGKRP
     LDSPEVEEMP SMKRPRLLST KGDSLDVVLL EAREPLSSIN PQKTPPVLSP VRVQDRADLA
     PPSPQPPMLA PFAKSQLPIA KPLETKSFTP KTKTKASSPG QKTKSPKAAL SPARLGSPIR
     SPKTIPKEKK SPGRSKSPKS PKSPKIVAHV PQTPVRPETP NRTPSAMVVE KTVKETIPVM
     KPTQTPPEVV KLNIEMQPKK PVVTDKTIDD SIDAVIARAC AEREPDPFEF SSGSESEGDT
     FTSPKRISGS ECATPKASTS SNNFTKSLAT PLPLSSGTSS SDNSWTMDAS IDEVVRKAKL
     GAPSNMPPTF PYISSPSISP PTPEPLHKGY EEKAKLPSSV DVKKKLKKEL KTKLKKKEKQ
     RDRERERERN KERSKEKDKM REREKEKEAG KELKYPWREL MKDEDSDPYK FKIKEFEDID
     AAKVRLKDGI VRREREKHKD KKKDRERSKR EKDKRERERL KEKNREDKIK APPTQLVLPP
     KEMALPLFSP SAVRVPAMLP AFSPMLPEKL FEEKEKPKEK ERKKDKKEKK KKKEKEKEKE
     KKEREREKER REREKREKEK EKHKHEKIKV EPVIPAPSPV IPRLTLRVGA GQDKIVISKV
     VPAPEAKPAP SLNRPKTPPP APVPIPVRVS PTPLQPPLLT QAAVCPALMP SPAPALSGIG
     SAKAPVRSVV TETVSTYVIR DEWGNQIWIC PGCNKPDDGS PMIGCDDCDD WYHWPCVGIM
     AAPPEEMQWF CPKCANKIKK DKKHKKRKHR AH
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024